Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Northwest Biotherapeutics Inc
NWBO | US
0.20
USD-0.01
-6.54%
NWBO | US
Loading StockChartView...
About Northwest Biotherapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
17/03/2026
Close
0.20
Open
0.22
High
0.22
Low
0.20
Northwest Biotherapeutics Inc. a biotechnology company develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product DCVax-L which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda Maryland.
View LessNWBO | US
Risk
49.4
Sharpe
-0.25
Luna's Score
28/100
Recommendation
Sell
Luna says (NWBO | US)
What's Working
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
50.6%1 month
49.4%3 months
82.9%6 months
75.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-11.91
Ent. to rev.
262.66
PEG
-
Other Fundamentals
EBITDA
-60.47M
MarketCap
250.65M
MarketCap(USD)
250.65M
Div. yield
-
Op. margin
-3.42K
Erngs. growth
-
Rev. growth
153.70
Ret. on equity
-
Short ratio
13.54
Short perc.
15.09
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.04
Range1M
0.05
Range3M
0.14
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
2.12
Price X volume
764.69K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -11.91 | 0.53 | Cheaper |
| Ent. to Revenue | 262.66 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 82.93 | 72.80 | Par |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 250.65M | 3.66B | Emerging |
